Search bioRxiv⌕ Search

Biology subjects

Linden, J.

Publications and source records attributed to Linden, J..

6 recordsLinked to original sources

Adenosine A2A and A2B receptor signaling in neurons promotes glucose and fatty acid release in the postprandial state

Adenosine is a widely distributed signaling molecule whose levels rise during conditions of metabolic stress, hypoxia, or inflammation. Adenosine is a homeostatic regulator of neuronal, cardiovascular, immune, and metabolic functions through activation of adenosine receptors. Here, we show that administration of adenosine rapidly elicits an immediate and pronounced excursion of glucose and non-esterified fatty acids (NEFA) in mice refed for four hours but is greatly attenuated in fasted mice. This adenosine-mediated postprandial response suggests that adenosine is a potent regulator of postprandial nutrient handling. Selective agonists and antagonists of A2A and A2B adenosine receptors demonstrate that activation of either is sufficient to evoke adenosines metabolic response, but both receptors must be inhibited simultaneously to abolish it. Adenosine strongly stimulates hepatic glucose production and adipose lipolysis, and this catabolic activity depends on sympathetic nerve activity as it requires autonomic signal transmission and is inhibited by blocking adrenergic receptors. Genetic ablation studies identify A2A and A2B receptors expressed on neurons, likely central neurons, as the primary site of action for mediating adenosines effects on whole-body metabolism. Collectively, these data demonstrate that acute adenosine administration promotes centrally mediated metabolic effects, particularly during the postprandial period. Rigorous dissection of signaling pathways shows that A2A and A2B receptors are individually sufficient and collectively necessary for adenosine-mediated glucose and fatty acid excursion.

physiology↗

Long-chain polyphosphates induce glomerular microthrombi and exacerbate LPS-induced acute kidney injury in mouse

Polyphosphates are evolutionarily conserved anionic polymers mediating pleiotropic functions in eukaryotes and prokaryotes, depending on their chain-length. Bacteria typically synthetize long-chains, while human platelets harbour exclusively medium-chains. Polyphosphate-mediated lung and liver-injury have been reported in experimental mouse models but their effects on the kidney remain undefined. Here we assessed kidney histopathology and cytokine levels following intravenous administration of medium-chain (P100) and long-chain (P700) polyphosphates and their synergistic effects with lipopolysaccharides (LPS) in mice. We found that P700 induced albuminuria, renal Kim-1 and Lcn2 transcription, focal renal damage with glomerular microthrombi, tubular degeneration, granular phenotype of slit diaphragm components nephrin and ZO1, and enlarged electron dense vesicles in podocyte cytoplasm indicating lysosome swelling. P700 combined with LPS induced marked multifocal acute tubular necrosis in the cortex, and augmented LPS-induced proinflammatory cytokine levels. No notable effects were seen with P100, indicating that PolyP-mediated kidney injury development is dependent on chain-length. We conclude that long-chain polyphosphates may play a procoagulant role behind kidney injury, by inducing microthrombi characteristic of thrombotic microangiopathy and augmenting cytokine levels under inflammatory conditions.

pathology↗

Free acid β-hydroxybutyrate supplementation does not ameliorate dextran sodium sulfate-induced colitis similar to ketogenic diet in male mice

High-fat, low-carbohydrate ketogenic diets have been found to alleviate experimental colitis in rodents. These diets lead to increased endogenous production and utilization of ketone bodies, such as {beta}-hydroxybutyrate (BHB), and supplementation with exogenous ketones has arisen as a potential alternative to ketogenic diets. This study aimed to investigate how continuous high-dose feeding with free acid BHB influences experimental colitis compared to a ketogenic diet with the hypothesis that BHB would also alleviate the inflammation. We fed nine-week-old C57BL/6J male mice for four weeks with one of three diets: a low-fat control diet, a ketogenic diet, or a low-fat diet supplemented with free acid R-BHB and then induced colonic inflammation with dextran sodium sulfate (DSS). We assessed macroscopic and histological changes in the colon, intestinal permeability to fluorescein isothiocyanate dextran, colonic mRNA expression of tight junction proteins and inflammatory markers, fecal calprotectin, and microbiota composition. While the ketogenic diet alleviated DSS-induced weight loss, macroscopic changes, and histological lesions, the BHB-supplemented diet did not have the same effect. The pre-DSS composition of the microbiota was drastically different between the diet groups which may partly explain the different outcomes. In conclusion, high-dose supplementation with free acid BHB may not produce the same benefits as ketogenic diet in the context of colonic inflammation.

pharmacology and toxicology↗

Tumour-derived LAMA5 is critical for tumour initiation and controls progression and phenotype in luminal breast cancer

Basement membrane (BM) supports and regulates the structural integrity, function and differentiation of epithelial tissues and protects against breast cancer invasion to stroma. Here we show that the BM component LAMA5 is critical for initiation of luminal mammary tumours, and controls tumour progression and phenotype development. LAMA5 is overexpressed in human breast carcinomas and LAMA5 downregulation attenuates growth of human breast cancer cells. Prepubertal luminal deletion of Lama5 in MMTV-PyMT mice results in marked reduction in emergence of early hyperplasias, along with a shift towards luminal progenitor-like phenotype. However, single allele deletion, but not biallelic deletion of Lama5 inhibits growth and progression towards advanced mammary carcinomas. Lama5 deficient luminal epithelial cells collectively display widespread alterations in Fibroblast growth factor (Fgf) signalling genes, including increased expression of Fgf receptor 2 (Fgfr2). Inhibition of Fgf receptors decreases growth and induces apoptosis also in biallelic-Lama5-deleted organoids without affecting wildtype organoids. Our results demonstrate a critical role for the BM component LAMA5 in mammary tumour initiation and reveal mechanisms of ECM-epithelial interplay in breast tumour progression and phenotype maintenance.

cancer biology↗

Feeding desensitizes A1 adenosine receptors in adipose through FOXO1-mediated transcriptional regulation

Adipose tissue is a critical regulator of energy balance that must rapidly shift its metabolism between fasting and feeding to maintain homeostasis. Adenosine has been characterized as an important regulator of adipocyte metabolism primarily through its actions on A1 adenosine receptors (A1R). We sought to understand the role A1R plays in adipocytes during fasting and feeding to regulate glucose and lipid metabolism by using an inducible, adiponectin-Cre with Adora1 floxed mice (FAdora1-/-), where F designates a fat-specific deletion. Fadora1-/- mice had impairments in the suppression of lipolysis by insulin on normal chow and impaired glucose tolerance on high-fat diet. FAdora1-/- mice also exhibited a higher lipolytic response to isoproterenol than WT controls when fasted, but not after a 4-hour refeeding period. We found that FOXO1 binds to the A1R promoter in adipocytes. Upon feeding, signaling along the insulin-Akt-FOXO1 axis leads to a rapid downregulation of A1R transcript and desensitization of adipocytes to A1R agonism. Obesity also desensitizes adipocyte A1R, and this is accompanied by a disruption of cyclical changes in A1R transcription between fasting and refeeding. We propose that FOXO1 drives high A1R expression under fasted conditions to limit excess lipolysis during stress and augment insulin action upon feeding. Subsequent downregulation of A1R under fed conditions facilitates reentrance into the catabolic state upon fasting.

physiology↗

Syn3 Gene Knockout Negatively Impacts Aspects of Reversal Learning Performance

Behavioral flexibility enables the ability to adaptively respond to changes in contingency requirements to maintain access to desired outcomes, and deficits in behavioral flexibility have been documented in many psychiatric disorders. Previous research has shown a correlation between behavioral flexibility measured in a reversal learning test and Syn3, the gene encoding synapsin III, which negatively regulates phasic dopamine release. Syn3 expression in the hippocampus, striatum, and neocortex is reported to be negatively correlated with reversal learning performance, so here, we utilized a global knockout line to investigate reversal learning in mice homozygous wildtype, heterozygous null, and homozygous null for the Syn3 gene. Compared to wildtype animals, we found a reversal specific effect of genetic Syn3 deficiency that resulted in a greater proportional increase in trials required to reach a preset performance criteria during contingency reversal, despite no observed genotype effects on the ability to acquire the initial discrimination. Behavioral flexibility scores, which quantified the likelihood of switching subsequent choice behavior following positive or negative feedback, became significantly more negative in reversal only for Syn3 homozygous null mice, suggesting a substantial increase in perseverative behavior in the reversal phase. Syn3 ablation reduced the number of anticipatory responses made per trial, often interpreted as a measure of waiting impulsivity. Overall, Syn3 expression negatively affected behavioral flexibility in a reversal specific manner but may have reduced waiting impulsivity.

genetics↗